RUA Life Sciences gains after numbers hint at profit
RUA Life Sciences Plc shares gained almost 10% Tuesday after the company posted a smaller first-half loss. But for investors, the main takeaway in the results was that its two operating cash engines nearly offset head-office costs before losses tied to Structural Heart and Vascular. The stock last traded at 19.50p, up 1.75p, or 9.86%, on delayed prints from 10:06 BST. Shares remain 27.2% under the 52-week peak of 26.80p hit on May 12, when the RUA Structural Heart spinout and funding were announced. Still, the shares are up 59.2% over 12 months, according to Investors Chronicle data.